Previous Article | Next Article ![]()
Infection and Immunity, May 2006, p. 2917-2924, Vol. 74, No. 5
0019-9567/06/$08.00+0 doi:10.1128/IAI.74.5.2917-2924.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Komfo Anokye Teaching Hospital, KNUST, Kumasi, Ghana,1 St. George's University of London, London, United Kingdom,2 St. Thomas' Hospital Campus, Guy's, King's and St. Thomas' School of Medicine, London, United Kingdom,3 St. Martin's Catholic Hospital, Agroyesum, Ghana,4 Nkawie Government Hospital, Nkawie, Ghana,5 Tepa Government Hospital, Tepa, Ghana6
Received 2 August 2005/ Returned for modification 21 September 2005/ Accepted 8 February 2006
Cytokine mRNA expression in biopsies of Mycobacterium ulcerans-infected human tissue was investigated using real-time PCR, and the findings were correlated with the clinical stages of disease and histopathologies. A broad range of cytokine mRNAs were detected in 16 early nodules and 28 late-stage ulcers, including those for the Th1 cytokines tumor necrosis factor alpha (TNF-
) and gamma interferon (IFN-
) and the Th2 cytokine interleukin 10 (IL-10). IFN-
was strongly expressed in both nodules and ulcers, suggesting that a Th1 response begins early in the disease. There was a significantly higher expression of IL-8 and other proinflammatory cytokines in results from 32 biopsies with neutrophilia than in those from 12 biopsies without acute inflammation. Ten tissue samples containing granulomas showed high mRNA expression for IFN-
, IL-1ß, IL-12p35, IL-12p40, IL-15, and TNF-
relative to 34 tissue samples without granulomas. These results suggest that the human immune response to M. ulcerans is similar to that seen with some other mycobacteria despite the presence of the toxin mycolactone in the tissues.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»